Shaanxi Meibang Pharmaceutical Group Co., Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Shaanxi Meibang Pharmaceutical Group Co., Ltd.

Why is Shaanxi Meibang Pharmaceutical Group Co., Ltd. ?

High Debt Company with a Debt to Equity ratio (avg) at times

Poor long term growth as Net Sales has grown by an annual rate of 9.81% and Operating profit at -42.10% over the last 5 years
High Debt Company with a Debt to Equity ratio (avg) at times
The company has been able to generate a Return on Equity (avg) of 7.87% signifying low profitability per unit of shareholders funds

Poor long term growth as Net Sales has grown by an annual rate of 9.81% and Operating profit at -42.10% over the last 5 years

Flat results in Sep 25

INTEREST(HY) At CNY 0.03 MM has Grown at 2,402.22%
PRE-TAX PROFIT(Q) At CNY -1.11 MM has Fallen at -220.55%

With ROE of 1.90%, it has a very expensive valuation with a 2.56 Price to Book Value

Over the past year, while the stock has generated a return of 7.63%, its profits have fallen by -33.2%

Underperformed the market in the last 1 year

The stock has generated a return of 7.63% in the last 1 year, much lower than market (China Shanghai Composite) returns of 22.49%

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Shaanxi Meibang Pharmaceutical Group Co., Ltd. should be less than 10%
Overall Portfolio exposure to Chemicals & Petrochemicals should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Chemicals & Petrochemicals)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Shaanxi Meibang Pharmaceutical Group Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Shaanxi Meibang Pharmaceutical Group Co., Ltd.

-13.59%

1.33

58.37%

China Shanghai Composite

16.78%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-2.41%

EBIT Growth (5y)

-26.85%

EBIT to Interest (avg)

60.71

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.22

Sales to Capital Employed (avg)

0.62

Tax Ratio

Tax Ratio is Negative%

Dividend Payout Ratio

41.67%

Pledged Shares

Institutional Holding

ROCE (avg)

8.59%

ROE (avg)

7.87%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.54

EV to EBIT

7.32

EV to EBITDA

4.92

EV to Capital Employed

0.40

EV to Sales

0.39

PEG Ratio

0.09

Dividend Yield

0.26%

ROCE (Latest)

5.51%

ROE (Latest)

4.42%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

Mildly Bearish

OBV

No Trend

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

19What is working for the Company

ROCE(HY)

Highest at 4.64%

DEBTORS TURNOVER RATIO(HY)

Highest at 5.03 times

RAW MATERIAL COST(Y)

Fallen by -14.89% (YoY

NET SALES(Q)

Highest at CNY 336.34 MM

OPERATING PROFIT(Q)

Highest at CNY 41.77 MM

PRE-TAX PROFIT(Q)

Highest at CNY 43.81 MM

NET PROFIT(Q)

Highest at CNY 34.72 MM

EPS(Q)

Highest at CNY 0.26

-7What is not working for the Company

INTEREST(9M)

At CNY 0.64 MM has Grown at inf%

OPERATING CASH FLOW(Y)

Lowest at CNY 199.1 MM

Here's what is working for Shaanxi Meibang Pharmaceutical Group Co., Ltd.

Debtors Turnover Ratio

Highest at 5.03 times and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Net Sales

Highest at CNY 336.34 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Operating Profit

Highest at CNY 41.77 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (CNY MM)

Pre-Tax Profit

Highest at CNY 43.81 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 34.72 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY 0.26

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Raw Material Cost

Fallen by -14.89% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Shaanxi Meibang Pharmaceutical Group Co., Ltd.

Interest

At CNY 0.64 MM has Grown at inf%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Operating Cash Flow

Lowest at CNY 199.1 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)